[HTML][HTML] The effect of biosimilar prescription targets for erythropoiesis-stimulating agents on the prescribing behavior of physicians in Germany
B Birkner, KE Blankart - Value in Health, 2022 - Elsevier
Objectives This study aimed to aid decision makers by analyzing the impact of introducing
biosimilar prescription targets on physician prescribing behavior in the prescription of …
biosimilar prescription targets on physician prescribing behavior in the prescription of …
The Effect of Biosimilar Prescription Targets for Erythropoiesis-Stimulating Agents on the Prescribing Behavior of Physicians in Germany
B Birkner, KE Blankart - Value in Health, 2022 - valueinhealthjournal.com
Objectives This study aimed to aid decision makers by analyzing the impact of introducing
biosimilar prescription targets on physician prescribing behavior in the prescription of …
biosimilar prescription targets on physician prescribing behavior in the prescription of …
The Effect of Biosimilar Prescription Targets for Erythropoiesis-Stimulating Agents on the Prescribing Behavior of Physicians in Germany
B Birkner, KE Blankart - Value in health: the journal of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives This study aimed to aid decision makers by analyzing the impact of introducing
biosimilar prescription targets on physician prescribing behavior in the prescription of …
biosimilar prescription targets on physician prescribing behavior in the prescription of …
The Effect of Biosimilar Prescription Targets for Erythropoiesis-Stimulating Agents on the Prescribing Behavior of Physicians in Germany.
B Birkner, KE Blankart - Value in Health: the Journal of the …, 2022 - europepmc.org
Objectives This study aimed to aid decision makers by analyzing the impact of introducing
biosimilar prescription targets on physician prescribing behavior in the prescription of …
biosimilar prescription targets on physician prescribing behavior in the prescription of …